A detailed history of Assetmark, Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Assetmark, Inc holds 354 shares of TEVA stock, worth $6,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
354
Previous 546 35.16%
Holding current value
$6,195
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$15.81 - $18.96 $3,035 - $3,640
-192 Reduced 35.16%
354 $6,000
Q2 2024

Aug 13, 2024

BUY
$12.78 - $17.4 $6,977 - $9,500
546 New
546 $8,000
Q3 2019

Nov 13, 2019

SELL
$6.16 - $9.6 $9,313 - $14,515
-1,512 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $292 - $565
-36 Reduced 2.33%
1,512 $14,000
Q1 2019

May 14, 2019

SELL
$15.58 - $20.01 $1,558 - $2,001
-100 Reduced 6.07%
1,548 $24,000
Q4 2018

Feb 13, 2019

SELL
$14.59 - $23.84 $11,672 - $19,072
-800 Reduced 32.68%
1,648 $25,000
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $2,527 - $3,078
-120 Reduced 4.67%
2,448 $53,000
Q2 2018

Aug 01, 2018

BUY
$16.77 - $24.71 $15,998 - $23,573
954 Added 59.11%
2,568 $62,000
Q1 2018

May 16, 2018

SELL
$16.68 - $22.07 $4,953 - $6,554
-297 Reduced 15.54%
1,614 $28,000
Q4 2017

Feb 13, 2018

SELL
$11.23 - $19.1 $718 - $1,222
-64 Reduced 3.24%
1,911 $36,000
Q3 2017

Nov 08, 2017

SELL
$15.41 - $32.17 $15,394 - $32,137
-999 Reduced 33.59%
1,975 $35,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,020 Added 52.2%
2,974 $99,000
Q1 2017

Sep 15, 2017

SELL
N/A
-2,173 Reduced 52.65%
1,954 $63,000
Q4 2016

Sep 15, 2017

SELL
N/A
-1,072 Reduced 20.62%
4,127 $150,000
Q3 2016

Sep 15, 2017

SELL
N/A
-595 Reduced 10.27%
5,199 $239,000
Q2 2016

Sep 15, 2017

BUY
N/A
719 Added 14.17%
5,794 $291,000
Q1 2016

Sep 15, 2017

SELL
N/A
-26,669 Reduced 84.01%
5,075 $272,000
Q4 2015

Sep 15, 2017

BUY
N/A
31,744
31,744 $2.08 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.